We are live on
!
Find out more
PBMWW
Psyence Biomedical Warrant
PBMWW
PBMWW
22 hedge funds and large institutions have $80.2K invested in Psyence Biomedical Warrant in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% less capital invested
Capital invested by funds: $80.5K → $80.2K (-$313)
4.13% less ownership
Funds ownership: 46.98% → 42.85% (-4.1%)
4% less funds holding
Funds holding: 23 → 22 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Holders
22
Holders Change
-1
Holders Change %
-4.35%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
3
Closed
4
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$5K
Top Buyers
| 1 |
LP
LMR Partners
London,
United Kingdom
|
+$2.66K |
| 2 |
VF
Virtu Financial
New York
|
+$672 |
| 3 |
Walleye Trading
New York
|
+$262 |
| 4 |
CS
Clear Street
New York
|
+$2 |
Top Sellers
| 1 |
CCM
Context Capital Management
Lajolla,
California
|
-$2.95K |
| 2 |
CSD
Clear Street Derivatives
New York
|
-$2.24K |
| 3 |
Walleye Capital
New York
|
-$2.18K |
| 4 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$1.88K |
| 5 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$1.25K |